# ERDERA Clinical Trial Call

**Funder:** Fondazione Telethon
**Deadline:** 16 November 2026
**Consortium:** Required — transnational consortium under the European Rare Diseases Research Alliance (ERDERA)
**TRL:** 4-7
**Frequency:** Annual
**Eligible countries:** IT
**Official call:** https://www.telethon.it/cosa-facciamo/ricerca/bandi-di-ricerca/erdera-clinical-trial-call-2026/
**Last updated:** 4 Nov 2026

## Eligibility & scope

Call for clinical trials on rare diseases under the ERDERA (European Rare Diseases Research Alliance) joint transnational initiative, with clinical-trial scope requiring patient-sample/clinical infrastructure.

## Summary

The ERDERA Clinical Trial Call, run in Italy by Fondazione Telethon as part of the European Rare Diseases Research Alliance (ERDERA), funds clinical trials on rare diseases that require a transnational consortium and access to patient-sample or clinical infrastructure. It targets researchers working at TRL 4-7, meaning the project must already have moved past basic discovery toward clinical testing. The call runs annually and is open to Italian applicants participating in an ERDERA transnational consortium.

## Who should apply

- Researchers in Italy with access to clinical-trial and patient-sample infrastructure
- Teams working on rare disease therapeutics at TRL 4-7
- Applicants able to join a transnational consortium under the ERDERA joint initiative
- Clinical and translational researchers rather than purely basic-science teams

## Key dates

- Deadline: 16 November 2026
- Call frequency: annual
- Consortium required: transnational, under the ERDERA joint initiative

## Tips for applicants

- Confirm your consortium's ERDERA eligibility and partner roles well before the deadline, since transnational coordination takes time to assemble.
- Document existing clinical infrastructure and patient-sample access explicitly, the TRL 4-7 scope means reviewers expect clinical readiness, not preclinical plans.
- Check Fondazione Telethon's national call text for Italy-specific administrative and funding-eligibility rules alongside the ERDERA joint call rules.

## Frequently asked questions

### What does the ERDERA Clinical Trial Call fund?

It funds clinical trials on rare diseases that fall within TRL 4-7 and require patient-sample or clinical infrastructure, run under the ERDERA transnational initiative.

### Who can apply to the ERDERA Clinical Trial Call through Fondazione Telethon?

Eligible applicants are based in Italy and must participate in a transnational consortium under the European Rare Diseases Research Alliance.

### Is a consortium required for this call?

Yes, applicants must form part of a transnational consortium under the ERDERA joint initiative.

### How often does the ERDERA Clinical Trial Call run?

It is an annual call.

### When is the deadline for the ERDERA Clinical Trial Call?

The deadline is 16 November 2026.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/fondazione-telethon-erdera-clinical-trial-call-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=fondazione-telethon-erdera-clinical-trial-call-2026).